Holen Sie sich die Stockscreener-App
11.83
3.19%
-0.39
Handel nachbörslich:
11.83
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.22
Offen:
$12.18
24-Stunden-Volumen:
6.37M
Relative Volume:
1.94
Marktkapitalisierung:
$2.36B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-5.715
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
-10.31%
1M Leistung:
-13.65%
6M Leistung:
-6.48%
1J Leistung:
-51.60%
1-Tages-Spanne:
$11.69
$12.19
1-Wochen-Bereich:
$11.69
$13.22
52-Wochen-Spanne:
$11.69
$24.93
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
11.83 | 2.44B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
429.59 | 159.08B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.56 | 54.20B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
272.00 | 40.55B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.05 | 36.85B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
261.77 | 18.95B | 2.96B | 487.70M | 344.00M | 6.6758 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Dentsply Sirona stock hits 52-week low at $12.14 - Investing.com
Pattern recognition hints at DENTSPLY SIRONA Inc. upside2025 Earnings Surprises & Fast Moving Market Watchlists - newser.com
Why DENTSPLY SIRONA Inc. (DY2) stock could be top winnerWeekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Aldo Denti joins Dentsply Sirona as chief commercial officer - Dental Tribune US
Will DENTSPLY SIRONA Inc. (DY2) stock issue positive guidanceLong Setup & Reliable Breakout Stock Forecasts - newser.com
Evercore ISI Group Maintains DENTSPLY SIRONA (XRAY) In-Line Recommendation - Nasdaq
DENTSPLY SIRONA to Host Investor Conference Call on November 6, 2025, for Q3 Financial Results - Quiver Quantitative
Dentsply Sirona to Host Third Quarter Conference Call on November 6th - GlobeNewswire
Nov. 6 webcast — Dentsply Sirona to host third-quarter results call at 8:30 AM ET - Stock Titan
DENTSPLY SIRONA (NASDAQ:XRAY) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
YieldBoost DENTSPLY SIRONA To 16.4% Using Options - Nasdaq
Evercore ISI Group Lowers Price Target for XRAY to $13.00 | XRAY Stock News - GuruFocus
U.S. Endodontics Devices Market: Strategic Growth and Emerging - openPR.com
Navigating Growth in the Dental Handpieces Market: A Data-Driven Perspective - openPR.com
United States Medical Implants Market Growth & Industry Outlook - openPR.com
A Look at DENTSPLY SIRONA’s (XRAY) Valuation Following Appointment of New Chief Commercial Officer - Sahm
Could Leadership Changes at DENTSPLY SIRONA (XRAY) Signal a New Approach to Commercial Execution? - Sahm
DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Down 4.3%Should You Sell? - MarketBeat
Why DENTSPLY SIRONA Inc. stock appeals to dividend seekers2025 Historical Comparison & Consistent Growth Stock Picks - newser.com
What institutional flow reveals about DENTSPLY SIRONA Inc.July 2025 Trends & Community Verified Trade Signals - newser.com
Will DENTSPLY SIRONA Inc. (DY2) stock beat value stocks2025 Price Targets & Long Hold Capital Preservation Tips - newser.com
Does DENTSPLY SIRONA Inc. show high probability of reboundOptions Play & High Accuracy Swing Trade Signals - newser.com
Best data tools to analyze DENTSPLY SIRONA Inc. stockJuly 2025 Action & Weekly Watchlist for Hot Stocks - newser.com
Dentsply Sirona (XRAY): Evaluating Valuation Potential After Recent Trading Interest - Yahoo Finance
Dentsply Sirona World 2025: Celebrating legacy and driving innovation - Oral Health Group
Dentsply Sirona announces executive transition and new advisory role - Investing.com
DENTSPLY SIRONA Announces Leadership Transition for Rosenzweig - TipRanks
Dentsply Sirona Hits 52-Week Low at $12.14 Amidst Significant Decline - Markets Mojo
World Smile Day Highlighted at DS World - Dentistry Today
Avantor Appoints Dentsply Sirona Chair Gregory Lucier to Board - MarketScreener
New Century Financial Group LLC Buys New Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
United States Dental Burs Market is expected to reach US$ 1587.83 - openPR.com
Dentsply Sirona appoints Aldo Denti as chief commercial officer By Investing.com - Investing.com Nigeria
Dental Implants Market Poised for Steady Growth by 2032, Driven by Innovation and Rising Surgical Procedures | DelveInsight - Barchart.com
J&J MedTech’s orthopedics head joins Dentsply Sirona as CCO - MassDevice
Dentsply Sirona appoints Aldo Denti as chief commercial officer - Investing.com
Dentsply Sirona Appoints Aldo M. Denti as Executive Vice President and Chief Commercial Officer - Quiver Quantitative
Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization - GlobeNewswire
Former J&J Orthopedics Chairman Aldo Denti Joins Dental Giant Dentsply Sirona as Commercial Chief - Stock Titan
1,159,840 Shares in DENTSPLY SIRONA Inc. $XRAY Bought by Ninety One UK Ltd - MarketBeat
Smile Train, Dentsply Sirona Helping More To Celebrate World Smile Day - Dentistry Today
Head-To-Head Contrast: Spotlight Innovation (OTCMKTS:STLT) and DENTSPLY SIRONA (NASDAQ:XRAY) - Defense World
Intraoral Scanner Market to Reach USD 1.43 Billion by 2035 | Align - openPR.com
Is DENTSPLY SIRONA Inc a good long term investmentTop Performing Stocks & Market Trend Real-Time Reports - earlytimes.in
BFI Infinity Ltd. Invests $335,000 in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Avior Wealth Management LLC Invests $546,000 in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA Inc. $XRAY Shares Acquired by Fifth Third Bancorp - Defense World
Acrylic Teeth Market Market 2025- 2032 Overview: Share, Size, - openPR.com
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):